Wall Street can wait: Why one U.S. biotech firm is listing in Hong Kong first
- Posted on July 21, 2026
- By CNBC
- 0 Views
- 1 min read
In brief
Generating AI summary…
Wall Street can wait: Why one U.S. biotech firm is listing in Hong Kong first
Global biotech firms are increasingly being drawn to Hong Kong for its growing investor base and proximity to Chinese pharmaceutical partners.
